Considering that COVID-19 vaccine sales are far, far below expected, is Pfizer still a safe stock to keep/buy? I've noticed the company's been in a cost-cutting mode for a while now, and in my opinion, that's never a good sign. A good company with good management should never resort to cuts to improve its results.
There are no replies in this thread yet. Be the first to post a reply below: